Yarrow Bioscience, Inc. (YARW)

Yarrow Bioscience Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025
Period Ending	Dec 31, 2025	Dec 31, 2025
Operating Income Operating Income Growth	-3.98	-3.98
Net Income Net Income Growth	-283.98	-283.98
Earnings Per Share EPS Growth	-66.82	-66.82
EPS Growth	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2025
Period Ending	Dec 31, 2025	Dec 31, 2025
Net Cash (Debt) Net Cash Growth	99.99	99.99
Net Cash Growth	-	-
Net Cash Per Share Net Cash Per Share Growth	23.53	23.53
Cash & Investments Cash & Investments Growth	99.99	99.99

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025
Period Ending	Dec 31, 2025	Dec 31, 2025
Operating Cash Flow Operating Cash Flow Growth	0.56	0.56
Free Cash Flow Free Cash Flow Growth	0.56	0.56
Free Cash Flow Growth	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 15, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 18, 2026

Data Sources Report a data error